Your browser doesn't support javascript.
loading
Egr1/HSP70 Promoter-Driven Activation of Gene Expression for Synergistic Anti-Hepatoma Using PEI-MZF Nanoparticles and Radiation.
Zhang, Jia; Dong, Min; Feng, Yan; Zhang, Dongsheng; Lin, Mei; Yuan, Chenyan; Li, Hongbo; Wang, Ling; Zhang, Hao; Liang, Chen.
Affiliation
  • Zhang J; Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, People's Republic of China.
  • Dong M; Imaging and Nuclear Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
  • Feng Y; Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, People's Republic of China.
  • Zhang D; Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, People's Republic of China.
  • Lin M; Imaging and Nuclear Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
  • Yuan C; Imaging and Nuclear Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
  • Li H; Imaging and Nuclear Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
  • Wang L; Imaging and Nuclear Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
  • Zhang H; Imaging and Nuclear Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
  • Liang C; Imaging and Nuclear Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
Int J Nanomedicine ; 17: 423-441, 2022.
Article in En | MEDLINE | ID: mdl-35115776

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Nanoparticles / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Int J Nanomedicine Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Nanoparticles / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Int J Nanomedicine Year: 2022 Document type: Article Country of publication: